Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival (PFS) as a first-line treatment for HER2 mutant advanced non-small cell lung cancer (NSCLC) in the DESTINY-Lung04 phase 3 trial.
INVL Private Equity Fund II has signed agreements to acquire Nordian Group and Norvelita, creating a EUR 200 million revenue fish processing group in Lithuania.
EfTEN United Property Fund reported a net loss of €143k in July 2026, despite a net profit of €566k for the first seven months of the year, down from €1.846M in the same period last year.
Trifork Group reported Q2 2026 adjusted organic revenue growth of 11% and adjusted EBITDA growth of 21%, driven by strong performance in Products and Services.
T-Mobile is expanding network recovery and customer support across Hawaiʻi following Hurricane Lala, with crews restoring affected sites and deploying portable generators.
HUTCHMED's SAFFRON Phase III trial showed ORPATHYS® (savolitinib) plus TAGRISSO® (osimertinib) significantly improved progression-free and overall survival in MET-driven EGFR-mutated lung cancer patients.
